Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Inovotion

Inovotion
2014 FOUNDED
PRIVATE STATUS
Accelerator/Inc LATEST DEAL TYPE
2 INVESTORS
Description

Developer of vivo oncology efficacy and toxicity assays designed to optimise pre-clinical and discovery studies. The company's technology finds the best anticancer candidate treatment by detecting the first in vivo toxicity effects of candidate compounds, enabling healthcare providers to accelerate the overall drug discovery process to answer unmet medical needs in oncology.

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Other Healthcare Services
Other Pharmaceuticals and Biotechnology
Primary Office
  • 5 Avenue du grand sablon
  • 38700
  • France

+33 04 00 00 00 00
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Inovotion’s full profile, request a free trial.

Inovotion Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator Completed Generating Revenue
1. Angel (individual) Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Inovotion Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Angelor Capitale Angel Group Minority 000 0000 000000 0
North Shore InnoVentures Accelerator/Incubator Minority 000 0000 000000 0

Inovotion Executive Team (1)

Name Title Board
Seat
Contact
Info
Jean Viallet Ph.D Co-Founder & Chief Executive Officer